These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3251666)

  • 81. Twenty-four hour variations of thyroid hormones and thyrotrophin concentrations in hypothyroid infants treated with L-thyroxine.
    Czernichow P; Wolf B; Fermanian J; Pomarede R; Rappaport R
    Clin Endocrinol (Oxf); 1984 Oct; 21(4):393-7. PubMed ID: 6509783
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Fasting decreases thyrotropin responsiveness to thyrotropin-releasing hormone: a potential cause of misinterpretation of thyroid function tests in the critically ill.
    Borst GC; Osburne RC; O'Brian JT; Georges LP; Burman KD
    J Clin Endocrinol Metab; 1983 Aug; 57(2):380-3. PubMed ID: 6408115
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Thyroid function tests in children with congenital hypothyroidism on L-thyroxine treatment.
    Volta C; Ghizzoni L; Davoli A; D'Amato L; Panza C; Bernasconi S
    Horm Res; 1989; 32(4):109-12. PubMed ID: 2625320
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Thyrotropin-releasing hormone stimulates growth hormone release from the anterior pituitary of hypothyroid rats in vitro.
    Szabo M; Stachura ME; Paleologos N; Bybee DE; Frohman LA
    Endocrinology; 1984 Apr; 114(4):1344-51. PubMed ID: 6423373
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Screening of geriatric patients for thyroid dysfunction with thyrotropin-releasing-hormone test, sensitive thyrotropin and free thyroxine estimation.
    Szabolcs I; Ploenes C; Bernard W; Herrmann J
    Horm Metab Res; 1990 May; 22(5):298-302. PubMed ID: 2112111
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Functional and morphological changes in the adenohypophysis of dogs with induced primary hypothyroidism: loss of TSH hypersecretion, hypersomatotropism, hypoprolactinemia, and pituitary enlargement with transdifferentiation.
    Diaz-Espiñeira MM; Mol JA; van den Ingh TS; van der Vlugt-Meijer RH; Rijnberk A; Kooistra HS
    Domest Anim Endocrinol; 2008 Jul; 35(1):98-111. PubMed ID: 18400449
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Serum TSH concentration as an aid to monitoring compliance with thyroid hormone therapy in hypothyroidism.
    England ML; Hershman JM
    Am J Med Sci; 1986 Nov; 292(5):264-6. PubMed ID: 3777010
    [TBL] [Abstract][Full Text] [Related]  

  • 88. TSH and thyroid hormones concentrations in patients with hypothyroidism receiving replacement therapy with L-thyroxine alone or in combination with L-triiodothyronine.
    Fadeyev VV; Morgunova TB; Sytch JP; Melnichenko GA
    Hormones (Athens); 2005; 4(2):101-7. PubMed ID: 16613812
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Variation in serum levels of T3, T4, FT4 and TSH during thyroxine replacement therapy.
    Wennlund A
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):47-9. PubMed ID: 3766048
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Iron deficiency anaemia in childhood and thyroid function.
    Tienboon P; Unachak K
    Asia Pac J Clin Nutr; 2003; 12(2):198-202. PubMed ID: 12810411
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Erythrocyte ouabain binding in patients receiving thyroxine.
    Wilcox AH; Levin GE
    Clin Endocrinol (Oxf); 1987 Aug; 27(2):205-12. PubMed ID: 2444369
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Computed tomography of the pituitary fossa in primary hypothyroidism. Effect of thyroxine treatment.
    Katevuo K; Välimäki M; Ketonen L; Lamberg BA; Pelkonen R
    Clin Endocrinol (Oxf); 1985 May; 22(5):617-21. PubMed ID: 4028460
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The replacement therapy problem in hypothyroidism.
    Leslie PJ; Toft AD
    Baillieres Clin Endocrinol Metab; 1988 Aug; 2(3):653-69. PubMed ID: 3066323
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis.
    Grant DJ; McMurdo ME; Mole PA; Paterson CR; Davies RR
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):529-33. PubMed ID: 8252740
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Short-term hypothyroidism has no effect on serum leptin concentrations.
    Simó R; Hernández C; Zafon C; Galofré P; Castellanos JM; Mesa J
    Diabetes Obes Metab; 2000 Oct; 2(5):317-21. PubMed ID: 11225748
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Falsely raised TSH levels due to human anti-mouse antibody interfering with thyrotropin assay.
    Santhana Krishnan SG; Pathalapati R; Kaplan L; Cobbs RK
    Postgrad Med J; 2006 Nov; 82(973):e27. PubMed ID: 17099084
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Metergoline inhibition of thyrotrophin and prolactin secretions in primary hypothyroidism.
    Delitala G; Rovasio PP; Masala A; Alagna S; Devilla L
    Clin Endocrinol (Oxf); 1978 Jan; 8(1):69-73. PubMed ID: 627092
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Effects of subclinical hyperthyroidism on renal handling of water and electrolytes in patients with nodular goiter.
    Corrales JJ; Tabernero JM; Miralles JM; Hernández MT
    Klin Wochenschr; 1991 Jan; 69(1):19-24. PubMed ID: 2016844
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Glutathione S-transferase in humans in health and disease.
    Hayes PC; Bouchier IA; Beckett GJ
    Gut; 1991 Jul; 32(7):813-8. PubMed ID: 1855690
    [No Abstract]   [Full Text] [Related]  

  • 100. Restoration of normal thyrotrophin secretion reduces the abnormally high serum glutathione S-transferase levels found in patients receiving thyroxine replacement therapy.
    Gow SM; Caldwell G; Toft AD; Sweeting VM; Beckett GJ
    Clin Endocrinol (Oxf); 1988 Sep; 29(3):249-56. PubMed ID: 3251666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.